LTRN vs NVR · $35.1M cap vs P/E 15, rev $4.21B
Lantern Pharma Inc (LTRN) versus NVR Inc (NVR) — a side-by-side from cached financials, not a winner call.
Lantern Pharma Inc (LTRN) is a biotechnology company listed on US.
NVR Inc (NVR) is a residential construction company listed on NYSE.
LTRN does not have a complete income-statement cache yet.
Latest reported NVR revenue for 2026-06-30 was $4.21B. Net income was $434.8M. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
LTRN currently screens at market cap $35.1M. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
Not investment advice. Open the LTRN and NVR stock pages for the full models.
Not investment advice.